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Background:Metal ions such as copper or zinc are involved in the development of neurodegenerative pathologies
andmetabolic diseases such as diabetesmellitus. Albumin structure and functions are impaired followingmetal-
and glucose-mediated oxidative alterations. The aim of this studywas to elucidate effects of Cu(II) and Zn(II) ions
on glucose-induced modiﬁcations in albumin by focusing on glycation, aggregation, oxidation and functional
aspects.
Methods: Aggregation and conformational changes in albumin were monitored by spectroscopy, ﬂuorescence
and microscopy techniques. Biochemical assays such as carbonyl, thiol groups, albumin-bound Cu, fructosamine
and amine groupmeasurements were used. Cellular assays were used to gain functional information concerning
antioxidant activity of oxidized albumins.
Results: Both metals promoted inhibition of albumin glycation associated with an enhanced aggregation and
oxidation process. Metal ions gave rise to the formation of β-amyloid type aggregates in albumin exhibiting im-
paired antioxidant properties and toxic activity tomurinemicroglia cells (BV2). The differential efﬁciency of both
metal ions to inhibit albumin glycation, to promote aggregation and to affect cellular physiology is compared.
Conclusions and general signiﬁcance: Considering the key role of oxidized protein in pathology complications,
glycation-mediated and metal ion-induced impairment of albumin properties might be important parameters
to be followed and fought.© 2014 Elsevier B.V. All rights reserved.1. Introduction
Protein alterations represent a growing interest in biophysical and
biochemical studies, since they are strongly associated in pathologies
such as neurodegenerative and metabolic diseases [1,2].
Glycation, also known as the Maillard reaction, is a slow non-
enzymatic reaction that initially involves attachment of glucose or
derivatives with free amine groups of protein to form reversibly a Schiff
base product, leading to the formation of stable fructosamine residuedvanced glycated end product;
in incubated at 37°C; MES, 2-
mide gel electrophoresis; PBS,
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d should be considered co-ﬁrst
ights reserved.(ketoamine) following Amadori rearrangement [3]. Further oxidation
and rearrangement of these early stage glycation products irrevers-
ibly give rise to advanced glycated end products (AGE) [4]. The
glycation process is often associated with oxidative phenomenon,
called “glycoxidation”, which occurs when oxidative reactions affect
the early stage glycation products [5].
Protein glycation and aggregation phenomenon are closely linked
since common structural and functional properties are shared by amy-
loid aggregate type proteins and glycated proteins. Main cellular recep-
tors for AGEs, including RAGE, CD36, MSR-A and MSR-B, are thought to
be also primary transporters of amyloid type peptides [6,7]. Besides,
protein glycation process could induce the formation of several types
of aggregates such as globular forms or amyloid ﬁbrils [8–10]. Terminal
glycation products are well known to be closely involved in neurode-
generative diseases by promoting amyloid deposit in brain [11]. In addi-
tion, protein aggregates can impair insulin secretion in type II diabetes
mellitus and indirectly promote glycation process of main circulatory
proteins [12].
In these pathologies, metal ions (mainly copper, iron and zinc) are
found to be highly concentrated within the core and periphery of
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Besides, high amount of metal ions can be related to diabetes mellitus
and neurological disorders [15]. If the role of these ions has not been
fully clariﬁed in vivo, several evidences suggest an inhibitor or promot-
ing action of these metal ions in the aggregation process depending on
themetal/protein ratio and the metal-ion bindingmode. Previous stud-
ies from our group showed a differential effect of Cu(II) and Zn(II) ions
in promoting bovine serum albumin or β-lactoglobulin aggregation
[16,17].
Metal ions may be present during protein glycation process and
metal-catalyzed oxidation reactions have several intersections with
post-translational protein modiﬁcation induced by glucose. Metal ion-
mediated glucose autoxidation leads to the formation of high reactive
carbonyl compounds [18]. Other studies reported a promoting role of
metal ions (ferric Fe3+ and cupric Cu2+) in α-oxoaldehyde formation
from early glycation products or Amadori products [19,20]. In organ-
isms, redox-active metals are transported by proteins. Among pro-
teins which could sequester metal in non-reactive forms, human
serum albumin represents the main target protein for glycoxidation.
This plasma protein could serve as a circulating depot for many drugs
and also metal ions [21,22]. In parallel, albumin is sustainably and
continually exposed to oxidative stresses impairing its beneﬁcial
properties [23].
Glycation of serum albumin has been widely studied in recent years
and the bovine form of albumin (BSA) constitutes the most common
molecular model used in glycation research ﬁeld. Even if albumin is
well-known to bind various cationic metals, no data are available on
the effect of these metals on albumin glycation. In order to clarify the
potential roles of metal on albumin glycation, we focused our study on
two metal ions: copper (II) and zinc (II). The glycation process of albu-
min in the presence or absence of metal was monitored by using bio-
physical (infrared and ﬂuorescence spectroscopy, AFM microscopy)
and biochemical (colorimetric and enzymatic assays) techniques. The
impact of metal ions on albumin functionality and cellular cytotoxicity
was also investigated.
2. Materials and methods
2.1. Materials
Non-recombinant bovine serum albumin (BSA) (cat# A9647),
CuCl2, ZnCl2 and D-(+)-Glucose were from Sigma. AGE (BSAG
samples) were prepared as previously described [24] by incubating
ﬁltered solutions of 0.4 mM BSA and 100 mM of glucose in MES
(4-morpholineethanesulfonic acid) buffer (pH 7.2), under sterile condi-
tions and nitrogen gas in capped vials at 37 °C for seven weeks. During
this preparation, solution of 1 mM or 3 mM of copper (CuCl2) or zinc
(ZnCl2) ions could be added. The proteins were dialyzed against MES
buffer, pH 7.2 and stored at −20 °C. For FTIR absorption measure-
ments, samples were washedwithMES, pH 7.2, prepared in D2O before
the measurements.
2.2. Absorption and ﬂuorescence measurements
Sampleswere diluted 1:60with buffer (6.6 μMBSA). UV/Vis absorp-
tion measurements were carried out on UV-2401PC Shimadzu spectro-
photometer tomonitor protein concentration at 280 nm. The calculated
molar absorptivity for bovine serum albumin is 46,824 M−1.cm−1 at
278 nm. Glycophore absorbance was measured at 340 nm. Spectra
were corrected for scattering contribution, and normalized to metal
ion absorption and to protein concentration.
Tryptophan, glycophore and Thioﬂavin-T ﬂuorescence emissions
were measured on our preparations (Jasco FP-6500). The tryptophan
emission spectra were determined in the 280–500 nm range (270 nm
excitation). AGE-related modiﬁcations were determined by measuring
glycophore ﬂuorescence at 425 nm under excitation at 345 nm.Fluorescence emission of Thioﬂavin-T was determined at 500 nm with
an excitation at 430 nm.
2.3. FTIR absorption measurements
IR spectra were recorded by a Bruker Vertex 70 spectrometer,
equipped with a MIR global light source (i.e. U-shaped silicon carbide
piece). The spectral resolution was 2 cm−1 and the total number of
scans for each spectrum was 100. All samples were placed between two
CaF2 windows, with a 0.05 mm Teﬂon spacer. The investigated infrared
zone is the region of the Amide I. Amide I band is due to an out of phase
combination of the C_O and C\N stretching modes of amide groups.
D2O solutionswere used in BSA samples to avoid the spectral overlaps be-
tween Amide I band and strong absorption band of water at 1640 cm−1.
The main component in the Amide I region of BSA infrared absorption is
located at about 1650 cm−1 and it is assigned to α-helices, the compo-
nent at about 1680 cm−1 is assigned to β-turns, and the component
at 1635 cm−1 is assigned to intra-molecular β-sheets.
2.4. Atomic force microscopy
Small aliquot (30 μl) of protein solution was loaded on freshly
cleaved mica. The samples were dried overnight under nitrogen ﬂux
and imaged. The instrument used for the AFMmeasurements in tapping
mode was a Veeco MultiMode V Scanning Probe Microscope. Etched-
silicon probes with Al-coating on detector side having a pyramidal-
shape tip with a nominal curvature b10 nm were used. During
scanning, the 125 ±10 μm long cantilevers, with a nominal spring con-
stant in the range of 40 N/m, oscillated at its resonance frequency
(330 kHz). Height, phase and amplitude error images were collected
by capturing 512 × 512 points in each scan, and the scan ratewasmain-
tained below 1 line per second. The worsening of the tips was moni-
tored by using a test pattern before and after every measurement
session.
2.5. Biochemical characterizations
Fructosamine was determined using the method developed by
Johnson et al. [25] with the nitroblue tetrazolium (NBT) reagent and fol-
lowing a protocol described in a previous study [26]. The results are
expressed as mmol/l of 1-deoxy-1-morpholinofructose (DMF), which
is a synthetic ketoamine used as a primary standard.
TNBS (2, 4, 6-trinitrobenzenesulfonic acid) assay is a sensitivemeth-
od for determining the primary free amino groups in proteins [27] and
was described in a previous study by our group [28]. Various concentra-
tions of L-glycine (10 to 200 nmol) were used as standards.
Thiol groups in native, modiﬁed albuminweremeasured by Ellman's
assay using 5, 5′-dithiobis, 2-nitrobenzoic acid (DTNB) [29] as described
previously [24]. A standard curvewas performed for each assay and used
various concentrations of L-cysteine (10 to 100 nmol) (Sigma). The con-
tent of thiol groups for each BSA sample was measured in duplicate on
two different quantities of BSA by reading the absorbance at 412 nm. Re-
sults were expressed as the number of free\SH groups per mol of BSA.
Aggregative modiﬁcations of glycated albumin samples in the presence
or absence of metal were analyzed by native and SDS-Polyacrylamide
Gels (12% of acrylamide) and stained by Coomassie blue according to
Laemmli's method [30]. Level of carbonylation of proteins was deter-
mined by spectrophotometric assay based on recognition of protein-
bound DNPH in carbonylated proteins with an anti-DNP antibody [31].
200 μg of protein lysates was precipitated and suspended with 0.5 ml
of DNPH solution (0.2% in 2 M HCl). Samples were incubated at room
temperature for 10 min and precipitated in 10% TCA solution before cen-
trifugation (2000 g for 2 min). Extraction of free DNPH from suspended
pellets was performed with 3 successive washes with ethanol–ethyl
acetate solution (50:50). Then dried protein pellets were dissolved in a
200 μl guanidine solution (6 M in 500 mM KCl pH 2.5). The absorbance
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and carbonyl contents, respectively. Carbonyl was expressed as mol
carbonyl/mol protein and determined by the following formula:
Carbonyl molð Þ=protein molð Þ ¼ DO370ð Þ  εM276protein
DO276−0:43  DO370ð Þð Þ  εM370hydrazone
!
In previous formula εM276 protein equals 46,824, molar absorptivity of
BSA and εM370 hydrazone equals 22,000, molar absorptivity of the
hydrazone [32].
2.6. Antioxidant properties of BSA samples
2.6.1. KRL or red blood hemolysis test
Each well of a 96 well-plate was ﬁlled with 100 μl (about 1.108
erythrocytes, 400,000 cells/μl ﬁnal concentration) of diluted solution
of red blood (1/10 in 0.15 M NaCl). Different albumin samples (10 μM
ﬁnal concentration) were added in triplicates. Hemolysis was started
by adding 0.45 M of AAPH in each well. Turbidimetry at 450 nm was
recorded in every 10 min using a 37 °C-thermostated microplate
reader. Results were expressed as 50% of maximal hemolysis time
(HT50 in min).
2.6.2. ORAC test
The ORAC assay using ﬂuorescein as the ﬂuorescent probe measures
the antioxidant capacity of samples to protect ﬂuorescein from AAPH-
induced oxidative damage. Thismethodwas described in detail in a pre-
vious study fromour group [33]. The automatedORAC assaywas carried
out on an Inﬁnite M200 pro spectroﬂuorometric analyzer (TECAN) at
excitation and emission wavelengths of 485 nm and 530 nm, respec-
tively. The reaction was carried out in phosphate buffer (75 mM,
pH 7.4) containing each albumin sample (25 μl) in six replicates and
ﬂuorescein solution (80 nM, 150 μl). Trolox solutions at different con-
centrations (6–50 μM)were used as calibration standards. The ﬂuores-
cence kinetics of ﬂuorescein was followed for 1 h at 37 °C after adding
automatically AAPH solution (150 mM, 25 μl) in each well. The ﬂuores-
cence was recorded every 2 min. Antioxidant curves (ﬂuorescence vs.
time) were ﬁrst normalized to the curve of the blank (phosphate buffer
instead of samples or trolox). Then the area under the ﬂuorescence
decay curve (AUC) was determined. The antioxidant activity (ORAC
value) of samples was calculated by using trolox calibration standards
as follows:
ORACvalue ¼ AUCsample−AUCblankð Þ
AUCTrolox 50 μMð Þ−AUCblankð Þ  Trolox½ = Sample½ ð Þ
Results were expressed as Trolox equivalent (μM) per μM of BSA.
2.7. Cell culture of BV2 microglia cells
Mouse BV2 microglia cells were cultured in completed DMEM
medium (10% FBS, penicillin (100 U/ml), streptomycin (100 U/ml)
and L-glutamine (2 mM)). Cells were grown in a 5% CO2 incubator at
37 °C. BV2 cells were cultured 24 h in a 96-well plate (10,000 cells/
well)with 200 μl DMEMcontaining 1% FBS (forMTT andDCF-DA assays)
or in a 6-well plate (300,000 cells/well) with 2 ml DMEM containing 1%
FBS (for direct cells count, TNF-α ELISA and annexin V-FITC and PI
staining) and treated with modiﬁed albumin samples (50 μM) or only
MES buffer (control).
2.8. MTT assay on BV2 cells
The MTT-assay, using the standard 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (Sigma), was chosen to evaluate
the effect of modiﬁed albumin samples on BV2 cell proliferation [34].
After overnight cell incubation, 20 μl of the MTT dye (5 mg/ml) wasadded into each well followed by 4 h of incubation. After discarding
media, 150 μl of dimethylsulfoxide (DMSO) was added into each well
and plates were agitated in the dark for 30 min to solubilize dark blue
formazan crystals. Absorbance was read at 595 nm wavelength. A well
containing medium alone (no cell and no treatment) was used for
zeroing absorbance.
2.9. Viable cell count
FACScan ﬂow cytometer (Becton-Dickinson) was used for the rela-
tive counting of viable BV2 cells. Equal amounts of FITC labeled beads
(CaliBRITE FITC-beads, 5 μm; BD Biosciences) were added to each cell
suspension just before the FACS-analysis. An electronic gate was set to
count the FITC-labeled beads. All BV2 cell and FITC-bead eventswere re-
corded, and when the number of counted FITC-labeled beads reached
2000, the counting process was stopped. A particular cell population
was selected by gating and was identiﬁed by its typical location in a
FSC v. SSC graph. Results were expressed as the percentage of cells
with respect to the control (BV2 treated with BSA).
2.10. Intracellular ROS formation
After 24 h of treatment, cells werewashed twicewith PBS, and incu-
bated with 10 μM dichloroﬂuorescin diacetate (DCFH-DA) during
30 min at 37 °C. Then, cells were washed with PBS and DCF ﬂuores-
cence was measured at 492 nm (excitation) and 520 nm (emission).
Fluorescence values were calculated after background subtraction
(identical conditions without DCFH-DA) and normalized by cell count.
Results were expressed as the percentage of DCF ﬂuorescence with
respect to the control.
2.11. Apoptosis and necrosis
After treatment BV2 cells were collected, washedwith PBS and incu-
batedwith 2 μg/ml Annexin V-FITC (BioLegend) and 2 μg/ml PI (Sigma)
in 100 μl binding buffer (BioLegend) for 15 min at RT and were ana-
lyzed using FACScan (BD Biosciences) and CellQuest software. Similarly
to the viable cell counting, a particular cell population was selected by
gating and was identiﬁed by its typical location in a FSC v. SSC graph.
2.12. IL-6 secretion
The proinﬂammatory cytokine IL-6 secretion in BV2 media after 6 h
of treatment in the presence of modiﬁed albumin samples (20 μM)was
quantiﬁed using a Human IL-6 ELISA Kit (eBioscience). Results are
expressed in pg secreted IL-6 per mg cellular proteins.
2.13. Copper binding afﬁnities of albumin
The level of copper ions bound to albumin can bemeasured spectro-
photometrically using bathocuproinedisulfonic acid (BC, Fluka #11870)
[35,36]. The protocol is well described in a previous study [26]. The
afﬁnity of albumin for copper was also determined by ﬂuorescence.
Thismethod is based on the quenching of albumin ﬂuorescence induced
by its interaction with metal [37]. The intrinsic ﬂuorescence of bovine
albumin ismainly attributed to the tryptophan residues. Different series
of assay solutionswere prepared bymixing 10 μMof native ormodiﬁed
BSA with copper chloride at concentrations ranging from 5 to 100 μM.
Each solution was incubated for 5 min at 25 °C and transferred into a
quartz cell. The ﬂuorescence spectra were recorded in the range of
250–500 nm under excitation at 283 nm. The binding parameters
(i.e. the binding constant KA and the binding site number n) for copper




¼ log KA þ n log C½ 
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sence and presence of a copper at concentration [C], respectively, and
KA is the formation constant of the complex formed between the drug
and albumin, expressed as l/mol.
2.14. Fluorescence data process and statistical analysis
For each ﬂuorescence spectrum, the zeroth (M0) and the ﬁrst (M1)
moments of the spectral distribution A (E) were calculated from the
experimental data, after subtracting the tangent to the minima of each










M0 measures the integrated intensity and M1 is the mean value of
the emission energy and measures the position of the band.
Biochemical data were expressed as themean ± standard deviation
(SD) from a minimum of three experiments. Statistical signiﬁcances
were determined using one-way ANOVA (followed by the Tukey's test).
3. Results
Preparations of native (BSA) or glycated albumin (BSAG) incubated
with or without X mM of Zinc (Zn) (X = 1 or 3) were labeled XZnBSA
or XZnBSAG. The same nomenclature was used for cooper (Cu)-treated
samples. Different glycated BSA samples incubated in the presence or
absence of metal ions were analyzed in order to determine the impact
of metals on albumin structure, conformation, morphology and func-
tionality during protein glycation process.Fig. 1. Involvement of metal in glycation process. a) Normalized absorption spectra of IncBSA (g
(gray dashed line), 1CuBSAG (black dashed and dotted line), 3CuBSAG (gray dashed and dotted
(λEm at 425 nm,λEx at 345 nm) in different glycated samples in respect to the emission intensit
in proteins by TNBS assay; d) Fructosamine levels obtainedwith the NBT assay; Histogramdata
in BSA glycation (vs. BSAG): ⁎⁎⁎p b 0.001, ⁎⁎p b 0.01,⁎p b 0.05.In order to analyzemetal ion impact on the protein glycation extent,
absorption measurements were performed on all albumin preparations
after their incubation for seven weeks at 37 °C. An increase in the
absorption band at around 300–380 nm reﬂects protein glycation as
this spectral range is attributed to the glycophore absorption [40]. On
Fig. 1a, we show normalized spectra of samples in order to compare
the different glycation extents. Albumins incubated with only glucose
(BSAG) or combined with 3 mM ZnCl2 (3ZnBSAG) gave rise to the
more glycated samples, while heated albumin (IncBSA)was not charac-
terized by any absorption contribution in this spectral range. In contrary
to 1CuBSAG sample which exhibits a low absorption at about 340 nm
suggesting a low small formation of AGE products, 3CuBSAG sample
revealed to have not any glycophore. These data are in accordance
with those obtained by ﬂuorescence spectroscopy at 425 nm emission
wavelength (Fig. 1b) and show that the efﬁciency of glycation process
decreased in the presence of copper ions. The presence of zinc, at any
concentration, caused a slight decrease in the glycation extent.
Due to their high nucleophile properties, lysine and arginine are the
sole residues prone to glycative modiﬁcation in the presence of glucose
[5]. As featured in Fig. 1c, native albumin exhibits about 33 free amine
residues. Glycation in the absence or presence of metal ions induced
a similar reduction in free amine groups (about −22% vs. BSA,
p b 0.01). This reduction was more marked for 3CuBSAG and 3ZnBSAG
(about−36% vs. BSA, p b 0.001).
In accordance with glycophore data, fructosamine early glycation
product was also reduced by the presence of metal ions (Fig. 1d).
Fructosamine levels (mol/mol of BSA) were totally reduced by copper
and partially by zinc ions in glycated BSA samples.
Structural modiﬁcations associated with glycoxidation, in particular
the tertiary structure conformationwere studied by tryptophanﬂuores-
cencemeasurements. The ﬂuorescence spectra featured in Fig. 2a, show
a typical band at about 340 nm (λex = 270 nm) attributed to the tryp-
tophan residue ﬂuorescence contribution (Trp 134 and Trp 214 in BSA).ray continuous line), BSAG (black continuous line), 1ZnBSAG (black dashed line), 3ZnBSAG
line); b) Glycation extent determined by glycophore ﬂuorescence intensity measurement
ymeasured for nonglycated sample (IncBSA); c)Unmodiﬁed primary amino group content
are expressed asmeans ± SD of three independent experiments. ⁎ Effect of copper or zinc
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incubated albumin (IncBSA), all modiﬁed albumins underwent a differ-
ential quenching of tryptophan ﬂuorescence as a consequence of pro-
tein incubation with glucose. The decrease in ﬂuorescence suggested
different tertiary structure modiﬁcations associated with an increase
in tryptophan exposure to the solvent ampliﬁed in the presence of
metals. These results indicated also that conformational changes could
be attributed to the simultaneous presence of glucose and metal. The
decrease in the intensity may be attributed to BSA glycoxidation, pro-
tein partial unfolding and aggregation process, as well. Moreover, the
normalized ﬂuorescence spectra featured in Fig. 2b revealed that ﬂuo-
rescence quenching was associated with modiﬁcation in the position
of the maximum band. Indeed, as indicated by the black arrow, a rela-
tive blue-shift of tryptophan glycophore (until 10 nm) was observed
for 1CuBSAG, 3ZnBSAG and 3CuBSAG. A blue-shift is typically due to a
less polar environment for both tryptophans and, when associated to
a reduction of the band width, it has also been attributed to the forma-
tion of more tightly packed structures. Even if both metals have the
same chemical valence, they differently affected the tertiary structure.
In the presence of 1 mM of zinc (II) no shift was revealed, while copper
(II) at the same concentration induced a blue-shift for the ﬂuorescence.
Analysis ofmomentum1 (M1) relative to the tryptophan emission for dif-
ferent albumin samples is reported in Fig. 2c. Quite similar blue-shifts
were observed for IncBSA, BSAG and 1ZnBSAG. Progressively higher M1
values observed for 1CuBSAG, 3ZnBSAG and 3CuBSAG suggested a less
polar environment for tryptophan as a consequence of the important con-
formational changes of protein in thepresence of copper(II) or zinc(II) po-
tentially associated with aggregation process [41].
The impact of glucose and metal on the secondary structure of BSA
was investigated by FTIR spectroscopy and corresponding spectra in
the region of the Amide I band are reported in Fig. 2d. The comparison
between native (BSA, circle symbol) with incubated albumins (IncBSAFig. 2. Contribution of metal in BSA unfolding. a) Fluorescence spectra of tryptophan (λEx = 2
dashed line), 3ZnBSAG (gray dashed line), 1CuBSAG (black dashed and dotted line), 3CuBSAG
citation wavelength at 270 nm of BSA samples above listed; c) momentum 1 (M1) for the tryp
samples above listed and native BSA (circle symbol). All measurements were made at room teand BSAG, continuous lines) indicated that the sole incubation at
37 °C induced an increase of intramolecular β-sheet and β-turn struc-
tures. The similar Amide I proﬁle observed for incubated BSA and
BSAG indicated that glycation process in the absence of metal ions did
not induce any protein secondary structure modiﬁcation. This result is
in full agreement with previous observations from our group [28]. The
presence of metal ions during albumin incubation and glycation miti-
gated the modiﬁcations of the secondary structure caused by heating.
Indeed, 1ZnBSAG, 1CuBSAG, 3ZnBSAG (not reported) and native BSA
(BSA in Fig. 2d) spectra resulted overlapped. A meaningful difference
wasnoticed for 3Cu-BSAG sample. The respective Amide I band featured
a marked shoulder at about 1619 cm−1 due to intermolecular β-sheet
structure contribution [41]. This result indicates that, in the presence
of glucose and 3 mM of copper (II), the aggregation process of BSA
prevailed on its glycation, as attested by the absence of absorption at
340 nm and glycophore emission at 345 nm.
The aggregative state of the samples was monitored by measuring
the Rayleigh scattering peak at 270 nm excitation wavelength. The sat-
uration of scattered intensities relative to 3ZnBSAG and 3CuBSAG sam-
ples observed in Fig. 3a reﬂected the formation of large aggregates. At
lower metal concentrations (1 mM), glycated albumin samples gave
similar values of scattered light markedly higher than those obtained
for BSAG and BSA. The native and SDS-PAGE electrophoresis proﬁles
of BSA samples corroborated these results (Fig. 3b). The retardation of
protein bands was observed in SDS-PAGE proﬁles for glycated albumin.
The increase of apparent molecular masses probably resulted from
boundglucose unit and/or aggregative process. The native PAGEproﬁles
showed the disappearance of band relative to the dimeric form of
glycated BSA in the presence of copper probably in favor of very high
molecular weight oligomers (not visible in the gel).
These results revealed the involvement of bothmetal ions in thepro-
motion of supramolecular aggregates during albumin incubation. This70 nm) of IncBSA (gray continuous line), BSAG (black continuous line), 1ZnBSAG (black
(gray dashed and dotted line); b) Normalized ﬂuorescence spectra of tryptophan with ex-
tophan band in the different BSA samples; d) Normalized FTIR absorption spectra of BSA
mperature after heat treatment of the protein solutions at pH 7.2.
Fig. 3.Differential contribution of metal in aggregation process. a) Rayleigh scattering peak made at room temperature and pH 7.2 for IncBSA (gray continuous line), BSAG (black contin-
uous line), 1ZnBSAG (black dashed line), 3ZnBSAG (gray dashed line), 1CuBSAG (black dashed and dotted line), 3CuBSAG (gray dashed and dotted line); c) Coomassie staining of BSA
samples separated by SDS-PAGE and native-PAGE electrophoresis (12%). Arrows (1) and (2) indicate the localization ofmonomeric and dimeric forms of BSA, respectively; c) ThT emission
(λEm at 500 nm, λEx at 430 nm) in different glycated samples in respect of the emission intensity measured for not glycated sample (BSA).
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tions which revealed a higher promoting effect of zinc, compared to
copper, in BSA aggregation [16,17].
Measurements of Thioﬂavin-T (ThT) ﬂuorescence in BSA samples
were performed in order to gain further insights into the presence ofFig. 4. Observation of BSA samples by atomic force microscopy. AFM images (height data) of a
equals 1 μm. Color scale represents height up to 5 nm.ﬁbrillar structures (Fig. 3c). The increasing interest on this molecule is
revealed by several recent studies dealing on ThT–ﬁbril interaction
[42–45]. Emission ﬂuorescence of ThT at 500 nm progressively in-
creased in the presence of growing concentration of metal ions during
albumin incubation with glucose. These results attest that ﬁbrillar) IncBSA; b) BSAG; c) 1ZnBSAG; d) 3ZnBSAG; e) 1CuBSAG and f) 3CuBSAG. The scale bar
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efﬁciency for copper.
Atomic forcemicroscopy (AFM)was used to observemodiﬁcation in
morphology and particle size of glycated protein in the presence and
absence of free metal ions during incubation process. As can be seen in
Fig. 4a, BSA aggregates exhibited globular morphologies with average
80–100 nm diameter. BSAG sample exhibited lower size (20–40 nm)
oligomers probably due to glucose bound to protein molecules
preventing the aggregation process (Fig. 4b). This is in agreement with
our previous results reporting the effects of glycation on albumin pro-
pensity to form aggregates [22]. A shown in Fig. 4c and d, the presence
of zinc led to larger aggregate formation. These aggregates, which in-
creased in number and size with metal concentrations, appeared to be
globular and amorphous types with the presence of some ﬁbrils long
up to fewmicrons (inset of Fig. 4d). This last observation is in accordance
with the increase of ThT ﬂuorescence previously shown. Compared to
zinc, copper led to the formation of BSA aggregates exhibiting linear
and supramolecular morphology (Fig. 4e and f). In agreement with the
Rayleigh scattering peak results, BSA aggregates formed during protein
glycation in the presence of copper were bigger but less numerous
than those formed with zinc.
Glycation process is commonly associated with the phenomenon of
oxidation affecting the early stage glycation products. The presence of
metal, particularly copper, could amplify protein oxidation. Redox
state in BSA samples was investigated by assessing free thiol group
content and carbonyl level (Fig. 5a and b). As expected, a signiﬁcant de-
crease in free thiol groups was measured following the sole incubation
at 37 °C of IncBSA (−10% vs. native BSA, p b 0.01) or the combined
incubation and glycation processes for BSAG (−34% vs. native BSA,
p b 0.001). Copper induced a more drastic decrease than zinc probably
contributing to an oxidation process to the detriment of glycation.
Accordingly to thiol results, levels of protein carbonyls for all albumin
samples evidenced a higher oxidation for glycated BSA strongly
increased in the presence of copper or 3 mM of zinc.
After determining that glycated albumin could be highly oxidized or
aggregated in the presence or absence ofmetal ions, we investigated the
functional integrity and cytotoxicity of these samples. Albumin is awell-
known antioxidant [23]. The intrinsic capacity of albumin to protect
erythrocytes from free radical-induced hemolysis was evidenced by a
higher hemolysis half-time (HT50) for IncBSA (+47.3% vs. MES,
p b 0.05) (Fig. 6a). This protective effect of albumin is a bit strengthened
with glycation and in the presence of copper or zinc ions. This increase
in BSA antiradical properties could not be ascribed to the sole scaveng-
ing properties of Cys 34 which appeared to be highly oxidized in
glycated samples. If the strengthened antiradical properties of CuBSAG
samples are also noticed in the ORAC test (+47.8%, vs. BSA, p b 0.01),
these properties were rather impaired in the presence of zinc (−60.5%,
vs. BSA, p b 0.001) (Fig. 6b). These conﬂicting results show that severalFig. 5. Effect ofmetal on BSA oxidation. a) Free thiol group content as assessed by the Ellman'sm
level in BSA samples expressed asmol of carbonyl/mol of BSA and assessed by Levine'smethod.
incubation and/or glycation (vs. native BSA): ⁎⁎⁎p b 0.001, ⁎⁎p b 0.01. # Effect of copper or zintests are necessary to assess the overall antioxidant capacity of the
protein.
The involvement of microglia in neurodegenerative process of
diseases was evidenced in many studies using BV2 microglia cell line
[46,47]. The effect of BSA samples on BV2 cell viability was evaluated
by using MTT assays and FACS. As shown in Fig. 7a, the MTT values de-
creased signiﬁcantly after 24 h incubation with 1CuBSAG (−25.4% vs.
BSAG, p b 0.05) and with 3CuBSAG (−53.6% vs. BSAG, p b 0.001). Zn
(II) ions gave rise to the formation of highly toxic aggregates in microg-
lia cells only for 3ZnBSAG (−62.7% vs. BSAG, p b 0.001). Similarly to
MTT results, the direct cell count showed a signiﬁcant decrease in the
number of viable BV2 cells when incubated in the presence of 3ZnBSAG
(−93.6% vs. BSAG, p b 0.01) or 3CuBSAG (−88.9% vs. BSAG, p b 0.01).
Analysis of apoptosis andnecrosis in BV2 cell usingAnnexin-V and PI
staining showed no increase in apoptotic nor necrotic cells above back-
ground levels for BV2 treatedwith BSA or BSAG (Fig. 8). The presence of
copper in BSAG samples resulted in elevated necrosis level in BV2 cells
(+14.3% for 1CuBSAG) while early apoptosis (+35.7%), late apoptosis
(+29.2%) and necrosis (+25%)were observed for microglia cells treat-
ed with 3CuBSAG. In the presence of 3ZnBSAG, BV2 cells were rather
apoptotic (71.3%) with a majority of early apoptotic cells (49.5%) in
comparisonwith the control (BSA). The oxidative state of BSAG samples
could play a role in the inhibition inmicroglia cell proliferation. Intracel-
lular ROS generation was assayed by using DCF-DA ﬂuorescent probe
(Fig. 9a). As expected, a signiﬁcant intracellular ROS increase was ob-
served in microglia treated with CuBSAG (+97% vs. BSAG, p b 0.01)
or with 3ZnBSAG (+151% vs. BSAG, p b 0.001). If oxidative stress
could contribute to affect cellular viability, we can also hypothesize a
pro-inﬂammatory action of our BSA preparations. However, as shown
in Fig. 9b, only 1ZnBSAG induced a signiﬁcant increase in IL-6 secretion
by microglia cells.
Our results suggest that copper ions exert inhibitory action on
glycation, ﬁbrillar aggregation and oxidation processes. In order to get
further insights into copper action, we investigated whether the pres-
ence of glucose could impact the afﬁnity of albumin for thismetal. Afﬁn-
itywasmeasured by using a spectroscopicmethod based on tryptophan
ﬂuorescence quenching of albumin. The maximum ﬂuorescence inten-
sity of native albumin at 337 nm, decreased with increasing concentra-
tions of CuCl2 (Fig. S1 see supplementary data) and this is probably
because copper ion acts as ﬂuorescent quencher via interactions with
the protein. Conversely, zinc ion did not induce any change in
quenching of tryptophan ﬂuorescence (data not shown). Hence, this
spectroscopic method is not suitable for investigating albumin afﬁnity
for zinc. The log plots ((F0 − FC) / FC) of BSAG0, BSAG25 and BSAG100 ver-
sus concentrations (log(C)) of copper are shown in Fig. 10a. These plots
exhibit a good linearity with the correlation coefﬁcients (r) above 0.957
(Table 1). The numbers of binding site n and the binding constants KA,
listed in Table 1 were calculated using these lines. The binding site nethod;Native BSA is albumin not subjected to incubation at 37 °C for 7 weeks. b) Carbonyl
Histogramdata are expressed asmeans ± SDof three independent experiments.⁎ Effect of
c in BSA glycation (vs. BSAG): ###p b 0.001, ##p b 0.01, #p b 0.05.
Fig. 6.Differential effect of glycated albumin in two in vitro free radical-scavenging activity tests: a) antioxidant activities were assessed by the free radical-mediated blood hemolysis test.
Histograms represent half-time hemolysis (HT50 in min) expressed as means ± SD of four independent experiments. The dotted line allows comparison with control (MES). b) Antiox-
idant properties of BSA samples were assessed using theORAC test. Histograms represent Trolox equivalent (μM)per albumin (μM) expressed asmeans ± sd (n = 5). ⁎ Effect of albumin
samples in erythrocytes (vs. MES): ⁎⁎⁎p b 0.001, ⁎⁎p b 0.01,⁎p b 0.05. # Effect of copper or zinc in glycated BSA samples (vs. BSAG): ###p b 0.001, ##p b 0.01, #p b 0.05.
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BSA afﬁnity for copper increased following protein glycation extent.
This suggests a structural modiﬁcation for albumin incubated with glu-
cose allowing a better binding of metal to the protein. This higher afﬁn-
ity could be explained by the increase in the number of binding sites
(from 1.1 to 1.7). Accordingly to this data, the levels of copper bound
to BSA samples (mol/mol of BSA), given in Fig. 10b, showed an increase
following glycation. Levels of copper bound to the protein incubated for
7 weeks in thepresence or absence of glucosewere assayed by the same
colorimetricmethod. As shown in Fig. 10c, copper ionsweremore likely
to bind BSA when incubated with glucose.
4. Discussions
Serum albumin plays important roles in the transport of many
metabolites including trace metals. If speciﬁc concentrations of these
metals are required for normal physiological functions, abnormal quan-
tity could impact health conditions. For instance, Zn(II) and Cu(II)
metabolism and concentrations could have a deleterious impact in dia-
betes development [15,48]. Cu(II), concentrations in blood serum were
reported to be signiﬁcantly higher in NID diabetesmellitus [49]. In addi-
tion, treatment with a copper chelating agent could consequently re-
duce insulin resistance and improve glucose intolerance. In addition,
plasma concentration of Zn(II) appears to be lower in diabetic patients
than in healthy subject and a treatment with Zn(II) exhibited beneﬁcial
effects in this disease [50]. Besides, numerous studies evidenced an
alteration in zinc metabolism in diabetes [48,51]. For instance, an
in vitro study showed that zinc depletion increases insulin vulnerability
to free radical-induced oxidation [52]. Circulating albumin glycationFig. 7. Cellular toxicity of metal BSAG samples. a) BV2 cellular cytotoxicity measured by MTT as
BV2 cells treated with BSA samples, expressed as the percentage of cells compared with BSA c
glycation in BV2 cell viability (vs. BSA): ⁎⁎⁎p b 0.001. # Effect of copper or zinc in glycated BSAand resulting AGE formation represent typical features of diabetes pa-
thology in which high afﬁnity metal ions such as copper or zinc could
be involved. These metal ions could potentially affect glycation and
AGE formation by taking part in complex formation with amino acids
[53]. Thus, the study of Zn(II) and Cu(II) impacts on the glycation pro-
cess of circulating proteins is of utmost importance.
The aim of this studywas to assess the role of Zn(II) and Cu(II) in the
structural modiﬁcation of BSA by focusing on the glycation, aggregation
and oxidation aspects. Themain results indicated that bothmetals exert
an inhibiting action in glucose-induced BSA glycation in a concentration
dependent manner. Also, copper ions appear to act as a more efﬁcient
inhibitor in glycation process than zinc. Indeed, Cu(II) ions are able to
reduce glycation (Amadori products) by a maximum of 94% while re-
duction reaches 48% with Zn (II) ions. There is no available evidence
about the role ofmetals in albumin glycation in vivo, but a study report-
ed the inhibitory effect of zinc in glycation of other proteins such as he-
moglobin [50]. Increase in albumin glycation is commonly associated
with a reduction of free amino groups such as lysine or arginine,
which represent the main available glycation sites [5]. The results pre-
sented here reveal that attenuation of glycation induced by metals is
not automatically associated with an increase in free primary amino
groups in protein. Modiﬁcation of these primary amino groups could
be attributed to a parallel process including aggregation or oxidation
initiated by the presence of both metal and glucose. Indeed, the pres-
ence of metal ions differently induces albumin aggregation during
glycation. Both Cu(II) and Zn(II) promoted the aggregation process
during glycation and induced aggregate formation exhibiting different
morphologies depending on the nature and concentration of the
metal. The important BSA unfolding in the presence of copper/glucosesay and expressed as a percentage of viability compared with control (MES). b) Viability of
ontrol and determined by a relative counting using a FACSscan ﬂow cytometer.⁎ Effect of
sample toxicity (vs. BSAG): ###p b 0.001, ##p b 0.01, #p b 0.05.
Fig. 8.Metal BSAG samples induced apoptosis and necrosis of microglia cells. FACS analysis of BV2 cells stained with Annexin-V (FL1) and PI (FL2) treated overnight with BSA samples
showed four different cell populations marked as: double negative (unstained) cells showing live cell population (lower left), Annexin V positive and PI negative stained cells showing
early apoptosis (lower right), PI positive and Annexin V negative stained cells showing dead cells (upper left) and ﬁnally Annexin V/PI double-stained cells showing late apoptosis
(upper right).
1720 J. Baraka-Vidot et al. / Biochimica et Biophysica Acta 1840 (2014) 1712–1724mixture is associated with a secondary structure evolution into inter-
molecular β-sheet structure in agreementwith the ﬁbrillar morphology
and bigger size of aggregates observed in AFM microscopy. The pres-
ence of β-amyloid like ﬁbril in CuBSAG or 3ZnBSAG structures could
explain their relative cytotoxicity for microglia cells. Several previous
studies have already highlighted this β-amyloid cytotoxicity of glycated
albumin [8,10].We can also notice that the partial conversion of second-
ary structure from α-helix into intramolecular β-sheets is rather
promoted by the sole incubation at 37 °C than the glycation process.
While the presence of 3 mM copper accentuates this conversion also
in favor of intermolecular β-sheet structures, other metal conditions
tend to mitigate the effect caused by heating. The tryptophanﬂuorescence is the main intrinsic probe used here to monitor the
denaturation and folding of proteins. However, the quenching of ﬂuo-
rescence could result either from partial unfolding or from protein oxi-
dation promoted by metal ions. As expected, both metals contribute to
an enhanced protein oxidation together with greater glycation and/or
aggregation processes in the presence of copper. Similarly to glycation
and aggregation phenomena, copper ions exhibit potent impact on ox-
idation process. The enhanced oxidative state was evaluated following
the redox status of Cys 34 and the carbonyl levels in albumin. Among
amino acids known to form carbonyl derivatives upon metal-catalyzed
oxidation, four of them (proline, arginine, lysine and threonine) are par-
ticularly prone to oxidation [54]. The particular susceptibility of arginine
Fig. 9.Metal glycated albumin enhanced intracellular oxidative stress and inﬂammation. a) Intracellular ROS production inmicroglia cells was determined by DCF ﬂuorescence assay. The
relative increase (%) in DCF ﬂuorescence (vs. MES) was determined for cells incubatedwith BSA samples (20 μM) during 24 h. Data are expressed as mean ± sd (n = 3). b) IL6 secretion
wasmeasured in BV2 cellmediumafter 6 h of incubationwith BSA samples (20 μM). Data is presented as % control (MES) and are expressed asmean ± sd (n = 3). ⁎ Effect of glycation in
BV2 cells (vs. IncBSA): ⁎⁎⁎p b 0.001, ⁎⁎p b 0.01. # Effect of copper or zinc in glycated BSA samples (vs. BSAG): ###p b 0.001, ##p b 0.01.
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crease in primary amino group level of glycated BSA is not be ascribable
to the sole glycation process which is partially or totally inhibited in the
presence of Cu(II) ions. Furthermore, the impact of the sole Cu(II) ions
on primary amino groups was observed (see Fig. S2, supplementary
data). The oxidation of these glycation sites by Cu(II) or Zn(II) ions
could explain the “antiglycative” potential of these metals. However,
our ﬁndings on the promoting role of Zn on BSA aggregation and oxida-
tion are in partial disagreement with another report stating a reduced
β-aggregation and thiol protection in the Zn-containing glycated BSAFig. 10. Bovine serum albumin afﬁnity for copper. a) The log plots ((F0 − FC) / FC) vs. log [C] fo
ﬂuorescence intensities of native albumin, BSAG0 ( ) and modiﬁed albumin, BSAG25 ( ) and B
b) Level of copper bound to glycatedBSA samples as assessed by theBCmethod (mol/mol of BSA
in the presence or absence of glucose (100 mM) and with copper (1 mM or 3 mM). Histogra
glycation in copper binding (vs. BSA): ⁎⁎⁎p b 0.001, ⁎⁎p b 0.01,⁎p b 0.05.samples [55]. Indeed, on the one hand, in the presence of Zinc(II) less
inter and intramolecular β-structures than IncBSA and BSAG were
formed (Fig. 2d). On the other hand, larger supramolecular structures
were revealed.
If metal ions have a determining role on albumin structure, they do
not drastically affect their antioxidant properties. Both in the red
blood cell hemolysis and in ORAC assays, the presence of copper in
BSA samples seems to reinforce the free radical trapping capacities of
albumin. However, the strengthening in the antiradical capacity of
glycated albumin following copper induced-oxidation appears to be inr copper chloride binding with native and diabetic albumin. F0 and FC are the tryptophan
SAG100 (▼) in the absence and presence of copper chloride at different concentrations [C];
). c) Level of copper bound to albumin (mol/mol of BSA) inBSA samples incubated 7 weeks
m data are expressed as means ± SD of three independent experiments. ⁎ Effect of BSA
Table 1
Binding parameters of copper in native and modiﬁed albumin preparations obtained by
ﬂuorescence spectroscopy. The binding studies of copper were investigated with 10 μM
albumin samples at 30 °C. The binding parameters: binding site number (n) and binding
constant KA were calculated as described in the Materials and methods section.
Binding constant KA
(l/mol) at 30 °C
Binding sites (n) Correlation
coefﬁcient (r)
Copper
BSAG0 9.29 × 104 1.119 ± 0.028 0.996
BSAG25 3.10 × 105 1.194 ± 0.113 0.957
BSAG100 6.74 × 107 1.724 ± 0.049 0.995
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ty of albumin seems not to be impaired, there is evidence that the pro-
tective role of the protein on cellular system is dramatically altered in
the presence of metals, as attested by MTT and FACS results. The cyto-
toxicity between both metal-modiﬁed albumins is found to be quite
different with a preferential necrotic pathway observed for murine mi-
croglia cells treated with CuBSAG while an apoptotic pathway seems to
be rather induced by 3ZnBSAG. Moreover, at low metal concentration
(1 mM), only CuBSAG leads to cellular toxicity associatedwith necrosis,
oxidative stress and inﬂammatory response.
This study gives newevidence that glycation and aggregation should
not be in general considered as two competitive processes. For instance,
Zn(II) ions promote the heat-induced aggregation of the protein with-
out completely preventing the glycation process. Conversely, in the
presence of Cu(II) ions, aggregation and glycation appear to be rather
competitive processes. If previous studies have demonstrated that ag-
gregation was a process normally associated with glycation [8–10], we
have also established that glycated albumin loses its capacity to self-
assembly into aggregates following thermal process [28].
In order to understand the several and differential effects of the two
investigated metal ions on the glycation, aggregation, oxidation pro-
cesses and the associated conformational changes, it was necessary to
focus on the speciﬁc and non-speciﬁc afﬁnities of bovine albumin forFig. 11. Proposed schematic models for the glycation- and oxidation-induced changes in the s
metal and glucose induces protein misfolding and formation of high cytotoxic β-amyloid-like a
The inhibitory roles played by Zn(II) and especially Cu(II) ions in glycation process could be att
other contributing factors for “antiglycative” properties of Cu(II) and Zn(II): (i) the main lysin
some of these amino acids could beprevented fromglycation because ofmetal coordinationwith
at close proximity of lysine or arginine which could induce a steric hindrance (see ②). (ii) Alter
could blunt the capacity of speciﬁc glycation sites to react with glucose residues (see ①).these metals. We propose schematic models (Fig. 11.) of glycation and
metal-induced changes in the structure and the properties of albumin.
The presence of metals induces protein oxidation and misfolding con-
tributing to the formation of highly cytotoxic aggregates responsible
of microglia activation and death. The differential effect of both metals
in glycation and aggregation could also result in the nature of the link
betweenmetal and protein whichwas already reported as different be-
tween copper and zinc [16,17,57]. Most mammalian albumins, such as
HSA or BSA, have four metal binding sites, including N-terminal site,
Cys34 residue and site A known to be identical to theMulti-Metal Bind-
ing site (MBS) located at the interface of domains I and II [58]. Another
metal binding site, called B,whose location remains unknownwas char-
acterized for some metals including Zn(II) [59]. In the metal-binding
site A, the imidazole nitrogens of His-67 in domain I and His-247 in do-
main II could be identiﬁed as main ligands for Zn(II) [60]. If site A is the
preferential site for Zn(II), it is also a secondary binding site for Cu(II)
[61,62].
Zinc is believed to be chelated by imidazole at histidine residues, but
some non-speciﬁc binding could also involve cysteine residues [63,64].
Regarding copper ions, serumalbumin has one strongbinding site in the
N-terminal tripeptide (Asp-Ala-His) for Cu(II), but histidine residues are
also suggested as a major ligand, similarly to cysteine [35]. Moreover a
previous study showed that both metals could be bound to albumin
via histidine-imidazole ring in the MBS/site A [17,60], or in N-terminal
site for copper [65]. Indeed, both nitrogen atoms of the 17 histidine res-
idues present in bovine albumin are potential donors for transition
metal ions. However, the mode of coordination of both these metals to
imidazole is different and does not involve the same nitrogen atom. Ac-
cording to Navarra et al., the ﬁrst mode of metal bindingwhich involves
Zn(II) ions, can promote intermolecular cross-link, leading to the forma-
tion of large aggregates, whereas Cu(II) ions are more prone to induce
intramolecular chelation. This different type of metal coordination
could explain why Zn(II) ions are more likely to promote the aggrega-
tion of BSA than Cu(II) ions in a heat-induced albumin treatment [17].
By contrast to this previous study, the presence of glucose gives rise totructure and the properties of BSA molecule. Glycoxidation of albumin in the presence of
ggregates triggering microglia cell apoptosis and necrosis associated with oxidative stress.
ributed to potential oxidation at lysine and arginine residues (see ①). We can hypothesize
e and arginine residues prone to glycation, are not involved in speciﬁc metal binding, but
adjacent or nearbyhistidine residues. Indeed,most histidine residues appear to be located
ation in the tertiary and secondary structures of BSA induced by binding with metals ions
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ings show that glucose could enhance albumin afﬁnity for copper.
Indeed, a higher copper level bound to BSAwas observedwhen glycated
or incubated with glucose. This increase in copper afﬁnity could be at-
tributed to a favorable conformational change (i.e. tertiary structure)
of albumin induced by glucose.
We previously indicated that the inhibitory roles played by Zn(II)
and especially Cu(II) ions in glycation process could be attributed to
potential oxidation at lysine and arginine residues (see ① in Fig. 11).
We can hypothesize other contributing factors for “antiglycative” prop-
erties of Cu(II) and Zn(II): (i) the main lysine and arginine residues
prone to glycation, are not involved in speciﬁc metal binding, but
some of these amino acids could be prevented from glycation because
of metal coordination with adjacent or nearby histidine residues.
Indeed, most histidine residues appear to be located at close vicinity of
lysine or arginine which could induce a steric hindrance (see ② in
Fig. 11). (ii) Alteration in the tertiary and secondary structures in BSA
induced by binding with metal ions could blunt the capacity of speciﬁc
glycation sites to react with glucose residues (see ① in Fig. 11). The dif-
ferent behavior of zinc and copper and in particular, the inhibiting role
played by copper in BSA glycation show that metal ions are non-
completely chelated by the protein through the main binding site and
highlights the role of non-speciﬁc binding sites in glycation, aggregation
and oxidation phenomena.
Themain limitation of our study concerns the use of non defatted al-
bumin. The zinc (II) secondary site is functionally linked to the fatty acid
binding site and defatted BSA may exhibit a different behavior in both
reactivity and spectral features upon glycoxidation. Studies on
glycoxidation effects on defatted albumin properties are under progress
in our laboratory.
In conclusion, we detailed the involvement of metal ions in the
glycation process causing structural modiﬁcations in glycated proteins.
In particular, we evidenced a marked inhibition of BSA glycation in the
presence of copper. We also ascertained that this metal could not be
considered as a protective agent regarding its deleterious role in protein
oxidation and aggregation by giving rise to cytotoxic aggregates. By con-
trast, zinc had moderate action on glycation and oxidation processes
even if it affected the extent of the aggregation similarly to copper. A
distinct polypeptide folding, redox states and metal binding mode of
both metal-glycated BSA systems could explain these differences.
These ﬁndings support the idea that the complexity in the interaction
between protein and metal requires further investigation by using
in vivomodel in order to reach a better understanding of the physiolog-
ical implication of Zn and Cu in albumin properties.Author contributions
J.B.V. researched data, contributed discussion, reviewedmanuscript.
G.N. researched data, wrote, contributed discussion, reviewed
manuscript.
M.L. researched data, reviewed manuscript.
E.B. contributed discussion, reviewed and edited manuscript.
V.M. contributed discussion, reviewed manuscript.
P.R. researched data, wrote, reviewed and edited manuscript.Acknowledgements
This work was supported by the Ministère de l'Enseignement
Supérieur et de la Recherche, the Ministère de l'Outre-Mer, the Conseil
Régional de La Réunion, the Université de La Réunion and l'Europe.
JBV is supported by a fellowship from the Conseil Régional de La
Réunion and l'Europe.
We are grateful to all members of the MBSM group (http://www.
ﬁsica.unipa.it/biophysmol/) for continuous stimulating discussions.Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbagen.2013.12.017.References
[1] S.B. Prusiner, S.J. DeArmond, Prion diseases and neurodegeneration, Annu. Rev.
Neurosci. 17 (1994) 311–339.
[2] M. Brownlee, Advanced protein glycosylation in diabetes and aging, Annu. Rev.Med.
46 (1995) 223–234.
[3] M.P. Cohen, Intervention strategies to prevent pathogenetic effects of glycated
albumin, Arch. Biochem. Biophys. 419 (2003) 25–30.
[4] M.P. Cohen, E. Shea, S. Chen, C.W. Shearman, Glycated albumin increases oxidative
stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and
stimulates ERK-dependent transforming growth factor-beta 1 production in
macrophage RAW cells, J. Lab. Clin. Med. 141 (2003) 242–249.
[5] P. Rondeau, E. Bourdon, The glycation of albumin: structural and functional impacts,
Biochimie 93 (2011) 645–658.
[6] I.S. Coraci, J. Husemann, J.W. Berman, C. Hulette, J.H. Dufour, G.K. Campanella, A.D.
Luster, S.C. Silverstein, J.B. El-Khoury, CD36, a class B scavenger receptor, is
expressed on microglia in Alzheimer's disease brains and can mediate production
of reactive oxygen species in response to beta-amyloid ﬁbrils, Am. J. Pathol. 160
(2002) 101–112.
[7] J.E. Donahue, S.L. Flaherty, C.E. Johanson, J.A. Duncan III, G.D. Silverberg, M.C. Miller,
R. Tavares, W. Yang, Q. Wu, E. Sabo, V. Hovanesian, E.G. Stopa, RAGE, LRP-1, and
amyloid-beta protein in Alzheimer's disease, Acta Neuropathol. 112 (2006)
405–415.
[8] B. Bouma, L.M. Kroon-Batenburg, Y.P. Wu, B. Brunjes, G. Posthuma, O. Kranenburg,
P.G. de Groot, E.E. Voest, M.F. Gebbink, Glycation induces formation of amyloid
cross-beta structure in albumin, J. Biol. Chem. 278 (2003) 41810–41819.
[9] N. Sattarahmady, A.A. Moosavi-Movahedi, F. Ahmad, G.H. Hakimelahi, M.
Habibi-Rezaei, A.A. Saboury, N. Sheibani, Formation of the molten globule-like
state during prolonged glycation of human serum albumin, Biochim. Biophys. Acta
1770 (2007) 933–942.
[10] Y. Wei, L. Chen, J. Chen, L. Ge, R. He, Rapid glycation with D-ribose induces globular
amyloid-like aggregations of BSA with high cytotoxicity to SH-SY5Y cells, BMC Cell
Biol. 10 (2009) 10.
[11] M.P. Vitek, K. Bhattacharya, J.M. Glendening, E. Stopa, H. Vlassara, R. Bucala, K.
Manogue, A. Cerami, Advanced glycation end products contribute to amyloidosis
in Alzheimer disease, Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 4766–4770.
[12] V. Bellotti, P. Mangione, G. Merlini, Review: immunoglobulin light chain
amyloidosis—the archetype of structural and pathogenic variability, J. Struct.
Biol. 130 (2000) 280–289.
[13] M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell, W.R. Markesbery, Copper,
iron and zinc in Alzheimer's disease senile plaques, J. Neurol. Sci. 158 (1998) 47–52.
[14] D. Religa, D. Strozyk, R.A. Cherny, I. Volitakis, V. Haroutunian, B. Winblad, J. Naslund,
A.I. Bush, Elevated cortical zinc in Alzheimer disease, Neurology 67 (2006) 69–75.
[15] M.P. Cohen, F.N. Ziyadeh, S. Chen, Amadori-modiﬁed glycated serum proteins and
accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications,
J. Lab. Clin. Med. 147 (2006) 211–219.
[16] G. Navarra, M. Leone, V. Militello, Thermal aggregation of beta-lactoglobulin in
presence of metal ions, Biophys. Chem. 131 (2007) 52–61.
[17] G. Navarra, A. Tinti, M. Leone, V. Militello, A. Torreggiani, Inﬂuence of metal ions on
thermal aggregation of bovine serum albumin: aggregation kinetics and structural
changes, J. Inorg. Biochem. 103 (2009) 1729–1738.
[18] S.P. Wolff, R.T. Dean, Glucose autoxidation and protein modiﬁcation. The potential
role of ‘autoxidative glycosylation’ in diabetes, Biochem. J. 245 (1987) 243–250.
[19] S. Kawakishi, J. Tsunehiro, K. Uchida, Autoxidative degradation of Amadori
compounds in the presence of copper ion, Carbohydr. Res. 211 (1991) 167–171.
[20] P.J. Thornalley, A. Langborg, H.S. Minhas, Formation of glyoxal, methylglyoxal and
3-deoxyglucosone in the glycation of proteins by glucose, Biochem. J. 344 (Pt 1)
(1999) 109–116.
[21] U. Kragh-Hansen, Structure and ligand binding properties of human serum albumin,
Dan. Med. Bull. 37 (1990) 57–84.
[22] T.J. Peters, All About Albumin — Biochemistry, Genetics, and Medical Applications,
Academic Press, San Diego, 1996.
[23] M. Roche, P. Rondeau, N.R. Singh, E. Tarnus, E. Bourdon, The antioxidant properties
of serum albumin, FEBS Lett. 582 (2008) 1783–1787.
[24] S. Chesne, P. Rondeau, S. Armenta, E. Bourdon, Effects of oxidative modiﬁcations
induced by the glycation of bovine serum albumin on its structure and on cultured
adipose cells, Biochimie 10 (2006) 1467–1477.
[25] R.N. Johnson, P.A. Metcalf, J.R. Baker, Fructosamine: a new approach to the estimation
of serum glycosylprotein. An index of diabetic control, Clin. Chim. Acta 127 (1983)
87–95.
[26] A. Guerin-Dubourg, A. Catan, E. Bourdon, P. Rondeau, Structural modiﬁcations of
human albumin in diabetic context, Diabetes Metab. 38 (2012) 171–178.
[27] S.L. Snyder, P.Z. Sobocinski, An improved 2,4,6-trinitrobenzenesulfonic acid method
for the determination of amines, Anal. Biochem. 64 (1975) 284–288.
[28] P. Rondeau, G. Navarra, F. Cacciabaudo, M. Leone, E. Bourdon, V. Militello, Thermal
aggregation of glycated bovine serum albumin, Biochim. Biophys. Acta Protein
Proteomics 1804 (2010) 789–798.
[29] G.L. Ellman, Tissue sulfhydryl groups, Arch. Biochem. Biophys. 82 (1959) 70–77.
1724 J. Baraka-Vidot et al. / Biochimica et Biophysica Acta 1840 (2014) 1712–1724[30] U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of
bacteriophage T4, Nature 227 (1970) 680–685.
[31] R.L. Levine, J.A.Williams, E.R. Stadtman, E. Shacter, Carbonyl assays for determination
of oxidatively modiﬁed proteins, Methods Enzymol. 233 (1994) 346–357.
[32] R.L. Levine, N. Wehr, J.A. Williams, E.R. Stadtman, E. Shacter, Determination of
carbonyl groups in oxidized proteins, Methods Mol. Biol. 99 (2000) 15–24.
[33] J. Baraka-Vidot, A. Guerin-Dubourg, F. Dubois, B. Payet, E. Bourdon, P. Rondeau, New
insights into deleterious impacts of in vivo glycation on albumin antioxidant activities,
Biochim. Biophys. Acta Gen. Subj. 1830 (2013) 3532–3541.
[34] T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application
to proliferation and cytotoxicity assays, J. Immunol. Methods 65 (1983) 55–63.
[35] M.D. Argirova, B.J. Ortwerth, Activation of protein-bound copper ions during
early glycation: study on two proteins, Arch. Biochem. Biophys. 420 (2003)
176–184.
[36] E. Bourdon, N. Loreau, L. Lagrost, D. Blache, Differential effects of cysteine andmethi-
onine residues in the antioxidant activity of human serum albumin, Free Radic. Res.
39 (2005) 15–20.
[37] S. Bi, L. Yan, Y. Sun, H. Zhang, Investigation of ketoprofen binding to human serum
albumin by spectral methods, Spectrochim. Acta A Mol. Biomol. Spectrosc. 78
(2010) 410–414.
[38] A. Marty, M. Boiret, M. Deumie, How to illustrate ligand–protein binding in a class
experiment: an elementary ﬂuorescent assay, J. Chem. Educ. 63 (1986).
[39] M. Leone, S. Agnello, R. Boscaino, M. Cannas, F.M. Gelardi, Conformational disorder
in vitreous systems probed by photoluminescence activity in SiO2, Anglais 60
(1999) 11475–11481.
[40] M. Stefek, I. Drozdikova, K. Vajdova, The pyridoindole antioxidant stobadine
inhibited glycation-induced absorbance and ﬂuorescence changes in albumin,
Acta Diabetol. 33 (1996) 35–40.
[41] P.M. Viallet, T. Vo-Dinh, A.C. Ribou, J. Vigo, J.M. Salmon, Native ﬂuorescence and
mag-indo-1-protein interaction as tools for probing unfolding and refolding
sequences of the bovine serum albumin subdomain in the presence of guanidine
hydrochloride, J. Protein Chem. 19 (2000) 431–439.
[42] M. Groenning, M. Norrman, J.M. Flink, M. van de Weert, J.T. Bukrinsky, G.
Schluckebier, S. Frokjaer, Binding mode of Thioﬂavin T in insulin amyloid ﬁbrils,
J. Struct. Biol. 159 (2007) 483–497.
[43] M. Groenning, L. Olsen, M. van deWeert, J.M. Flink, S. Frokjaer, F.S. Jorgensen, Study
on the binding of Thioﬂavin T to beta-sheet-rich and non-beta-sheet cavities,
J. Struct. Biol. 158 (2007) 358–369.
[44] M.R. Krebs, E.H. Bromley, A.M. Donald, The binding of thioﬂavin-T to amyloid ﬁbrils:
localisation and implications, J. Struct. Biol. 149 (2005) 30–37.
[45] R. Khurana, C. Coleman, C. Ionescu-Zanetti, S.A. Carter, V. Krishna, R.K. Grover, R.
Roy, S. Singh, Mechanism of thioﬂavin T binding to amyloid ﬁbrils, J. Struct. Biol.
151 (2005) 229–238.
[46] A. Henn, S. Lund, M. Hedtjarn, A. Schrattenholz, P. Porzgen, M. Leist, The suit-
ability of BV2 cells as alternative model system for primary microglia cultures
or for animal experiments examining brain inﬂammation, ALTEX 26 (2009)
83–94.[47] B. Liu, J.S. Hong, Role of microglia in inﬂammation-mediated neurodegenerative
diseases: mechanisms and strategies for therapeutic intervention, J. Pharmacol.
Exp. Ther. 304 (2003) 1–7.
[48] C. Seneviratne, G.W. Dombi, W. Liu, J.A. Dain, The in vitro glycation of human serum
albumin in the presence of Zn(II), J. Inorg. Biochem. 105 (2011) 1548–1554.
[49] A. Tanaka, H. Kaneto, T. Miyatsuka, K. Yamamoto, K. Yoshiuchi, Y. Yamasaki, I.
Shimomura, T.-a. Matsuoka, M. Matsuhisa, Role of copper ion in the pathogenesis
of type 2 diabetes, Endocr. J. 56 (2009) 699–706.
[50] R.A. Al-Maroof, S.S. Al-Sharbatti, Serum zinc levels in diabetic patients and effect of
zinc supplementation on glycemic control of type 2 diabetics, Saudi Med. J. 27
(2006) 344–350.
[51] M.D. Chen, Y.M. Song, P.Y. Lin, Zinc effects on hyperglycemia and hypoleptinemia in
streptozotocin-induced diabetic mice, Horm. Metab. Res. 32 (2000) 107–109.
[52] P. Faure, J.L. Lafond, C. Coudray, E. Rossini, S. Halimi, A. Favier, D. Blache, Zinc
prevents the structural and functional properties of free radical treated-insulin,
Biochim. Biophys. Acta 1209 (1994) 260–264.
[53] D.T. Ramonaityte, M. Kersiene, B. Mockaitiene, The interaction of heavy metals
(Cu, Fe, and Zn) with Maillard reaction products in the lactose–glycine system,
Ann. N. Y. Acad. Sci. 1043 (2005) 889.
[54] E.R. Stadtman, Oxidation of free amino acids and amino acid residues in proteins by
radiolysis and bymetal-catalyzed reactions, Annu. Rev. Biochem. 62 (1993) 797–821.
[55] R.S. Tupe, V.V. Agte, Role of zinc along with ascorbic acid and folic acid during
long-term in vitro albumin glycation, Br. J. Nutr. 103 (2010) 370–377.
[56] E. Bourdon, N. Loreau, D. Blache, Glucose and free radicals impair the antioxidant
properties of serum albumin, FASEB J. 13 (1999) 233–244.
[57] G. Navarra, D. Giacomazza, M. Leone, F. Librizzi, V. Militello, P.L. San Biagio, Thermal
aggregation and ion-induced cold-gelation of bovine serum albumin, Eur. Biophys. J.
38 (2009) 437–446.
[58] W. Bal, M. Sokolowska, E. Kurowska, P. Faller, Binding of transition metal ions to
albumin: sites, afﬁnities and rates, Biochim. Biophys. Acta 1830 (2013) 5444–5455.
[59] G. Fanali, Y. Cao, P. Ascenzi, M. Fasano, Mn(II) binding to human serum albumin: a
(1)H-NMR relaxometric study, J. Inorg. Biochem. 117 (2012) 198–203.
[60] A.J. Stewart, C.A. Blindauer, S. Berezenko, D. Sleep, P.J. Sadler, Interdomain zinc site
on human albumin, Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3701–3706.
[61] W. Bal, J. Christodoulou, P.J. Sadler, A. Tucker, Multi-metal binding site of serum
albumin, J. Inorg. Biochem. 70 (1998) 33–39.
[62] P.J. Sadler, J.H. Viles, 1H and 113)Cd NMR investigations of Cd(2+) and Zn(2+)
binding sites on serum albumin: competition with Ca(2+), Ni(2+), Cu(2+), and
Zn(2+), Inorg. Chem. 35 (1996) 4490–4496.
[63] B. Deng, Y. Wang, P. Zhu, X. Xu, X. Ning, Study of the binding equilibrium between
Zn(II) and HSA by capillary electrophoresis-inductively coupled plasma optical
emission spectrometry, Anal. Chim. Acta. 683 (2010) 58–62.
[64] E.L. Giroux, R.I. Henkin, Competition for zinc among serum albumin and amino
acids, Biochim. Biophys. Acta Gen. Subj. 273 (1972) 64–72.
[65] C. Hureau, H. Eury, R. Guillot, C. Bijani, S. Sayen, P.L. Solari, E. Guillon, P. Faller, P.
Dorlet, X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes:
inﬂuence on their redox properties, Chemistry 17 (2011) 10151–10160.
